Trial · NCT04493931
Participant flow378
How many started, completed or left each group, period by period.
1 to 20 of 378
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Cohort1:Treatment Period 1(Up to 3 Days) | STARTED | Cohort 1: Gepotidacin 1500 mg/Cimetidine + Gepotidacin 1500 mg | 14 | |
| Cohort1:Treatment Period 1(Up to 3 Days) | STARTED | Cohort 2: Gepotidacin 1500 mg/Gepotidacin 1500 mg + Rifampicin | 0 | |
| Cohort1:Treatment Period 1(Up to 3 Days) | STARTED | Cohort 3: Digoxin+Midazolam/Gepotidacin 3000 mg + Digoxin + Midazolam | 0 | |
| Cohort1:Treatment Period 1(Up to 3 Days) | STARTED | Cohort 3: Gepotidacin 3000 mg + Digoxin + Midazolam/Digoxin+Midazolam | 0 | |
| Cohort1:Treatment Period 1(Up to 3 Days) | STARTED | Cohort 4:Gepotidacin 1500 mg Fed/Gepotidacin 1500 mg Fasted/Gepotidacin 3000 mg Fed | 0 | |
| Cohort1:Treatment Period 1(Up to 3 Days) | STARTED | Cohort 4:Gepotidacin 1500 mg Fasted/Gepotidacin 1500 mg Fed/Gepotidacin 3000 mg Fed | 0 | |
| Cohort1:Treatment Period 1(Up to 3 Days) | STARTED | Cohort 4: Placebo Fed/ Placebo Fasted/ Placebo Fed | 0 | |
| Cohort1:Treatment Period 1(Up to 3 Days) | COMPLETED | Cohort 1: Gepotidacin 1500 mg/Cimetidine + Gepotidacin 1500 mg | 13 | |
| Cohort1:Treatment Period 1(Up to 3 Days) | COMPLETED | Cohort 2: Gepotidacin 1500 mg/Gepotidacin 1500 mg + Rifampicin | 0 | |
| Cohort1:Treatment Period 1(Up to 3 Days) | COMPLETED | Cohort 3: Digoxin+Midazolam/Gepotidacin 3000 mg + Digoxin + Midazolam | 0 | |
| Cohort1:Treatment Period 1(Up to 3 Days) | COMPLETED | Cohort 3: Gepotidacin 3000 mg + Digoxin + Midazolam/Digoxin+Midazolam | 0 | |
| Cohort1:Treatment Period 1(Up to 3 Days) | COMPLETED | Cohort 4:Gepotidacin 1500 mg Fed/Gepotidacin 1500 mg Fasted/Gepotidacin 3000 mg Fed | 0 | |
| Cohort1:Treatment Period 1(Up to 3 Days) | COMPLETED | Cohort 4:Gepotidacin 1500 mg Fasted/Gepotidacin 1500 mg Fed/Gepotidacin 3000 mg Fed | 0 | |
| Cohort1:Treatment Period 1(Up to 3 Days) | COMPLETED | Cohort 4: Placebo Fed/ Placebo Fasted/ Placebo Fed | 0 | |
| Cohort1:Treatment Period 1(Up to 3 Days) | NOT COMPLETED | Cohort 1: Gepotidacin 1500 mg/Cimetidine + Gepotidacin 1500 mg | 1 | |
| Cohort1:Treatment Period 1(Up to 3 Days) | NOT COMPLETED | Cohort 2: Gepotidacin 1500 mg/Gepotidacin 1500 mg + Rifampicin | 0 | |
| Cohort1:Treatment Period 1(Up to 3 Days) | NOT COMPLETED | Cohort 3: Digoxin+Midazolam/Gepotidacin 3000 mg + Digoxin + Midazolam | 0 | |
| Cohort1:Treatment Period 1(Up to 3 Days) | NOT COMPLETED | Cohort 3: Gepotidacin 3000 mg + Digoxin + Midazolam/Digoxin+Midazolam | 0 | |
| Cohort1:Treatment Period 1(Up to 3 Days) | NOT COMPLETED | Cohort 4:Gepotidacin 1500 mg Fed/Gepotidacin 1500 mg Fasted/Gepotidacin 3000 mg Fed | 0 | |
| Cohort1:Treatment Period 1(Up to 3 Days) | NOT COMPLETED | Cohort 4:Gepotidacin 1500 mg Fasted/Gepotidacin 1500 mg Fed/Gepotidacin 3000 mg Fed | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04493931/flow